Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

18-Jan-2009

  • EPCA-2 testing more accurate way to identify cancer in the prostate (News-Medical-Net)

    New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.


  • IMA meet on prostate enlargement (Indian Express via Yahoo! India News)

    A clinical meeting was organised on Sunday by the Indian Medical Association on Benign Prostatic Hyperplasia clinical manifestations and management . The meeting was presided over by Dr Diwakar Dalela, the HOD, Urology Department, King George s Medical University (KGMU). Around 20 to 30 doctors from all over the city attended the meting. They later approached Dr Dalela for their queries regarding ...


  • The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With ... (Medical News Today)

    UroToday.com- Nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment according to a report by Dr. Oh and colleagues in the online version of Cancer.ZA is an intravenous bisphosphonate given to decrease skeletal related events in CaP patients with bone metastases. [click link for full article]


  • GTX Shares Fall on Study Concern (AP via Yahoo! Finance)

    Shares of biotechnology company GTX Inc. stumbled Monday on concerns on the risks involved with a late-stage study of the company's prostate cancer drug Acapodene.


  • Back to Prostate News Archive